GCP
MDCO

GSA Capital Partners’s Medicines Co MDCO Stock Holding History

GSA Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,009
Closed -$252K – 1880
2019
Q1 		$252K Buy
+9,009
New +$212K 0.03% 1103
2017
Q2 		– Sell
-6,400
Closed -$313K – 2074
2017
Q1 		$313K Buy
+6,400
New +$292K 0.02% 1363
2016
Q2 		– Sell
-6,840
Closed -$217K – 1995
2016
Q1 		$217K Sell
6,840
-13,500
-66% -$441K 0.01% 1457
2015
Q4 		$759K Buy
20,340
+2,859
+16% +$108K 0.04% 899
2015
Q3 		$664K Sell
17,481
-7,364
-30% -$258K 0.03% 939
2015
Q2 		$711K Sell
24,845
-76,133
-75% -$2.12M 0.03% 1135
2015
Q1 		$2.83M Buy
+100,978
New +$2.84M 0.11% 183
2014
Q2 		– Sell
-9,116
Closed -$259K – 2028
2014
Q1 		$259K Buy
9,116
+3,740
+70% +$124K 0.02% 1234
2013
Q4 		$208K Sell
5,376
-15,092
-74% -$540K 0.02% 1444
2013
Q3 		$686K Buy
20,468
+5,580
+37% +$178K 0.05% 576
2013
Q2 		$458K Buy
+14,888
New +$498K 0.05% 597

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

GSA Capital Partners's MDCO Position: Q2 2019 in Review

GSA Capital Partners sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 9,009 shares — an estimated $252K sold.

GSA Capital Partners first reported a position in MDCO in Q2 2013 and held it in 11 quarters. The position peaked at $2.83M in Q1 2015. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • GSA Capital Partners reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
  • GSA Capital Partners sold 9,009 Medicines Co shares in Q2 2019, an estimated $252K.
  • GSA Capital Partners first reported a position in Medicines Co in Q2 2013 and held it in 11 quarters.
  • GSA Capital Partners's Medicines Co position peaked at $2.83M in Q1 2015.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on GSA Capital Partners's 13F filing for Q2 2019, filed 6 Aug 2019.